Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
Launched by SOUTHWEST AUTISM RESEARCH & RESOURCE CENTER · Mar 24, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how certain biological markers in the body relate to neurological and developmental disorders like Autism Spectrum Disorder (ASD), epilepsy, brain tumors, and other related conditions. Researchers hope to understand the connections between metabolism (how our body uses food for energy) and our immune system in these disorders. If you or your child is between the ages of 0 and 17 and has been diagnosed with ASD or other specified conditions, you may be eligible to participate.
Participants can expect to visit the study site up to five times for simple procedures, including a blood draw (when you give a small sample of blood), behavioral assessments, and questionnaires about health and behavior. There is no cost for any of the visits or tests related to this study. It’s important to note that participants cannot have had serious reactions to blood draws in the past, and females who are pregnant or planning to become pregnant cannot participate. This study is currently looking for participants, and your involvement could help improve understanding of these conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria (ASD):
- • 1. ASD, as defined by either a gold standard measure for ASD diagnosis, the Autism Diagnostic Observation Schedule (ADOS); the Autism Diagnostic Interview-Revised (ADI-R); and/or a comprehensive assessment that is consistent with ASD, in the opinion of the principal investigator. For those the PI believes a prospective diagnosis of ASD is warranted, a formal diagnostic assessment will be scheduled at screening.
- • 2. 0 years through 17 years 11 months of age
- • Inclusion Criteria (TD, MD, Epilepsy, Brain Tumor, Psychiatric)
- • 1. 0 years to 17 years 11 months of age
- Exclusion Criteria (All):
- • 1. History of a significant adverse reaction to a prior blood draw
- • 2. In females of reproductive age, pregnancy or plans to become pregnant
- • 3. Any other historical event/information that may, in the opinion of the PI, be a reason to exclude the child from participation.
About Southwest Autism Research & Resource Center
The Southwest Autism Research & Resource Center (SARRC) is a leading nonprofit organization dedicated to advancing research and providing comprehensive resources for individuals with autism spectrum disorder (ASD) and their families. With a commitment to innovation and evidence-based practices, SARRC conducts rigorous clinical trials aimed at enhancing understanding of autism and developing effective interventions. The center collaborates with researchers, healthcare professionals, and community organizations to foster a supportive environment that promotes the well-being and development of individuals with ASD. Through its initiatives, SARRC strives to empower families and improve outcomes for those affected by autism.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Phoenix, Arizona, United States
Brooklyn, New York, United States
Phoenix, Arizona, United States
Patients applied
Trial Officials
Richard E Frye, MD, PhD
Study Director
Autism Discovery & Treatment Foundation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials